DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1

[1]  Xin Zheng,et al.  TPX2 as a novel prognostic biomarker for hepatocellular carcinoma , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  S. Zhang,et al.  Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma , 2015, Journal of experimental & clinical cancer research : CR.

[3]  F. Zheng,et al.  Baicalein increases the expression and reciprocal interplay of RUNX3 and FOXO3a through crosstalk of AMPKα and MEK/ERK1/2 signaling pathways in human non-small cell lung cancer cells , 2015, Journal of experimental & clinical cancer research : CR.

[4]  Wenbin Guo,et al.  MicroRNA‐520g induces epithelial–mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7 , 2015, FEBS letters.

[5]  Jingbo Kang,et al.  Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma , 2014, Journal of experimental & clinical cancer research : CR.

[6]  Sangmyung Rhee,et al.  The intracellular juxtamembrane domain of discoidin domain receptor 2 (DDR2) is essential for receptor activation and DDR2‐mediated cancer progression , 2014, International journal of cancer.

[7]  Carlo La Vecchia,et al.  Hepatocellular carcinoma epidemiology. , 2014, Best practice & research. Clinical gastroenterology.

[8]  Zhang Yan,et al.  Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein. , 2014, Biochimica et biophysica acta.

[9]  K. Tu,et al.  Effects of microRNA‐30a on migration, invasion and prognosis of hepatocellular carcinoma , 2014, FEBS letters.

[10]  Xin Zheng,et al.  TPX2 knockdown suppressed hepatocellular carcinoma cell invasion via inactivating AKT signaling and inhibiting MMP2 and MMP9 expression. , 2014, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[11]  B. Bonavida,et al.  Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention , 2014, Journal of experimental & clinical cancer research : CR.

[12]  W. Lu,et al.  Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma , 2014, Cancer biology & therapy.

[13]  Kevin W. Eliceiri,et al.  The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis , 2013, Nature Cell Biology.

[14]  Jia Liu,et al.  Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma , 2013, BMC Cancer.

[15]  J. Qu,et al.  Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling. , 2013, Carcinogenesis.

[16]  J. Muntané,et al.  Targeting tyrosine kinase receptors in hepatocellular carcinoma. , 2013, Current cancer drug targets.

[17]  S. Qiu,et al.  High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma , 2013, Journal of experimental & clinical cancer research : CR.

[18]  L. Yao,et al.  Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients , 2013, Medical Oncology.

[19]  Jia Liu,et al.  Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma , 2013, BMC Cancer.

[20]  H. Ford,et al.  Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity , 2011, Breast Cancer Research.

[21]  R. Aft,et al.  Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial–Mesenchymal Transition Predicts for Human Breast Cancer Recurrence , 2011, Molecular Cancer Research.

[22]  B. Leitinger,et al.  Transmembrane collagen receptors. , 2011, Annual review of cell and developmental biology.

[23]  Yan Li,et al.  Overexpression of Cathepsin Z Contributes to Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma , 2011, PloS one.

[24]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[25]  A. Zhu,et al.  The role of signaling pathways in the development and treatment of hepatocellular carcinoma , 2010, Oncogene.

[26]  M. Petz,et al.  Epithelial-mesenchymal transition in hepatocellular carcinoma. , 2009, Future oncology.

[27]  S. Altekruse,et al.  Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  C. la Vecchia,et al.  Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004 , 2008, Hepatology.

[29]  Ching‐Hwa Tsai,et al.  Upregulation of discoidin domain receptor 2 in nasopharyngeal carcinoma , 2008, Head & neck.

[30]  S. Cheung,et al.  Mechanism of metastasis by membrane type 1-matrix metalloproteinase in hepatocellular carcinoma. , 2005, World journal of gastroenterology.

[31]  F. X. Bosch,et al.  Epidemiology of hepatocellular carcinoma. , 2005, Clinics in liver disease.

[32]  B. Olsen,et al.  Activation of the Discoidin Domain Receptor 2 Induces Expression of Matrix Metalloproteinase 13 Associated with Osteoarthritis in Mice*♦ , 2005, Journal of Biological Chemistry.

[33]  S. Friedman,et al.  Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2* , 2002, The Journal of Biological Chemistry.

[34]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[35]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[36]  T. Pawson,et al.  The discoidin domain receptor tyrosine kinases are activated by collagen. , 1997, Molecular cell.

[37]  G. Yancopoulos,et al.  An orphan receptor tyrosine kinase family whose members serve as nonintegrin collagen receptors. , 1997, Molecular cell.

[38]  M. Colombo,et al.  Epidemiology of hepatocellular carcinoma. , 1995, The Italian journal of gastroenterology.